AstraZeneca Plans to Invest $50 Billion in America for Medicines Manufacturing and R&D
July 22, 2025
July 22, 2025
WILMINGTON, Delaware, July 22 -- AstraZeneca, a biopharmaceutical company, issued the following news release on July 21, 2025:
* * *
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
Investment will support AstraZeneca's ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Cornerstone of investment is a proposed new multi-billion dollar drug substance manufacturing center focu . . .
* * *
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
Investment will support AstraZeneca's ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Cornerstone of investment is a proposed new multi-billion dollar drug substance manufacturing center focu . . .